Company: IXHL
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001213900-25-036057
Chunk: 42

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 42
---
 retain key personnel and to provide a means whereby our and our affiliates’ directors, employees, and consultants (and prospective directors, employees, and consultants) can acquire and maintain an equity interest 23 in the Company, or be paid incentive compensation, which may, but need not, be measured by reference to the value of our shares of common stock, thereby strengthening their commitment to the success of the Company and its affiliates and aligning their interests with those of our stockholders. Eligibility and administration.Employees, consultants, and directors of the Company and its affiliates, as well as prospective employees, consultants, and directors who have accepted offers of employment or consultancy from the Company or its affiliates are eligible to receive one or more types of Awards (as defined below) under the Amended 2023 Plan. The Amended 2023 Plan is administered by a committee of two directors (the “Committee”). Currently, Mr. Widdows and Mr. Clark are members of the Committee. The Committee has complete authority to determine which employees, consultants, and/or non -employeedirectors will be granted Awards under the Amended 2023 Plan. The Committee members must qualify as “non -employeedirectors” under Rule 16b -3of the Exchange Act. Subject to the terms of the Amended 2023 Plan, the Committee has all discretion and authority to administer the Amended 2023 Plan and to control its operation, in accordance with the Amended 2023 Plan’s provisions, including, but not limited to, the power to (a) determine which employees, consultants, and non -employeedirectors will be granted Awards, (b) prescribe the terms and conditions of the Awards (which need not be the same), (c) interpret the Amended 2023 Plan and the Awards, (d) adopt such procedures and/or subplans deemed necessary or appropriate for the purpose of satisfying applicable international laws or for qualifying for favorable tax treatment under applicable international laws, (e) to institute and determine the terms and conditions of an award exchange program; provided, however, that the Committee shall not implement an award exchange program without the approval of the majority of the Company’s stockholders entitled to vote at any annual or special meeting of the Company’s stockholders, and (f) make whatever rules it considers appropriate for the administration and interpretation of the Amended 2023 Plan. The Committee may delegate any of its authority and powers under the Amended 2023 Plan to one or more officers